Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Ozge Bayrak Demirel
With
The Scientific and Technological Research Council of Turkey
Istanbul University
Cytochrome P450 Oxidoreductase (POR) deficiency is a rare autosomal recessive condition associated with congenital adrenal hyperplasia and other systemic complications. This study aims to elucidate the role of endothelial dysfunction and hypertension in POR deficiency by comparing the biochemical, vascular, and clinical parameters of POR-deficient patients with age- and gender-matched healthy controls. The research could pave the way for targeted therapeutic interventions.
Age
7–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Genetically confirmed diagnosis of Cytochrome P450 Oxidoreductase (POR) deficiency
Diagnosis of POR deficiency before the age of 18.
Written informed consent provided by the participant and/or their legal guardian.
You may not be if
Presence of an acute illness or other pathology identified during the study. Nail-biting habit or manicure within the last 14 days (due to potential impact on capillaroscopy results)
Use of medications other than physiologic hydrocortisone
Kidney, endocrine, or vascular pathologies that may cause hypertension